NCT04725097终止不适用
Rapid Throughput Screening for Human COVID-19 Infection: A ECG Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- Mayo Clinic
- 入组人数
- 2,821
- 试验地点
- 8
- 主要终点
- COVID 19 Detection
研究概览
简要总结
The purpose of this study is to assess the ability of an artificial intelligence smartphone-enabled point of care ECG to detect COVID-19.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 89 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult males and females age 18 or greater.
- •Undergoing COVID-19 testing by PCR.
- •Willing and able to provide informed consent.
- •Pregnant females (minimal risk study, no risk from ECG).
排除标准
- •Unwilling or unable to provide informed consent.
结局指标
主要结局
COVID 19 Detection
时间窗: One time screening within 4 hours of PCR test
Determine the safety and feasibility of the POC AI-ECG's ability to detect active SARS-Cov-2 infection in humans.
次要结局
未报告次要终点
研究者
Elie F. Berbari
Principal Investigator
Mayo Clinic
研究点 (8)
Loading locations...
相似试验
已完成
不适用
Rapid Detection of COVID-19 by Portable and Connected Biosensor : Biological Proof of ConceptSARS-CoV InfectionCovid19NCT04780334University Hospital, Lille200
已完成
不适用
Rapid, Onsite COVID-19 DetectionCOVID-19Sars-CoV2NCT04460690University of Wisconsin, Madison93
Unknown
不适用
COVID-19 Diagnostic Self-testing Using Virtual Point-of-careCommunicable DiseaseCOVID-19Sars-CoV2Infectious DiseaseCoronavirusVirusNCT04348864Neuroganics LLC200
已完成
不适用
COVID-19 Self-testing StudyCOVID-19NCT05701878Columbia University100
尚未招募
不适用
AI-enabled Screening and Diagnosis of Cardiomyopathies Using Coronary CTAMyocarditisCardiovascular DiseasesHypertrophic Cardiomyopathy (HCM)Dilated Cardiomyopathy (DCM)Amyloid CardiomyopathyCardiomyopathiesIschemic CardiomyopathyArrhythmogenic Right Ventricular CardiomyopathyRestrictive CardiomyopathyNCT06748261Shanghai Zhongshan Hospital5,000